0001728411-19-000001.txt : 20190315
0001728411-19-000001.hdr.sgml : 20190315
20190315142944
ACCESSION NUMBER: 0001728411-19-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190315
DATE AS OF CHANGE: 20190315
EFFECTIVENESS DATE: 20190315
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: DMC Biotechnologies, Inc.
CENTRAL INDEX KEY: 0001728411
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-303493
FILM NUMBER: 19684638
BUSINESS ADDRESS:
STREET 1: 5333 EUCLID AVENUE
CITY: BOULDER
STATE: CO
ZIP: 80303
BUSINESS PHONE: (303) 210-2829
MAIL ADDRESS:
STREET 1: 5333 EUCLID AVENUE
CITY: BOULDER
STATE: CO
ZIP: 80303
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001728411
DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
BOULDER
CO
COLORADO
80301
(720) 239-7239
DELAWARE
None
None
Corporation
true
2017
Matthew
L.
Lipscomb
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Executive Officer
Director
Michael
D.
Lynch
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Director
Rob
van der Meij
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Director
Carolyn
Fritz
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Director
Biotechnology
Decline to Disclose
- 06b
true
0001728411-18-000001
2018-01-04
true
true
true
true
false
0
2537660
2537660
0
Offer and Sale of Series Seed Preferred Stock and Series Seed Preferred Stock Warrants (and the shares issuable thereunder)
false
3
0
0
0
false
DMC Biotechnologies, Inc.
Matthew L. Lipscomb
Matthew L. Lipscomb
Chief Executive Officer
2019-03-15